Pfizer Halts Ranbaxy's Diflucan Generic With Court Ruling
The U.S. District Court in Washington, D.C. has upheld Pfizer's six-month pediatric exclusivity for its top selling anti-fungal medicine, Diflucan....To view the full article, register now.
Already a subscriber? Click here to view full article